Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Oct 31, 2017
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-10-30$6.03/sh−2,582$15,569→ 139,700 total
Footnotes (2)
- [F1]Sale of a total of 2,582 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 8,229 shares of restricted stock on October 27, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 82,392 shares of restricted stock.